Description

Pioglit MF 15 Tablet ER is a combination medicine containing Pioglitazone (15mg) and Metformin (500mg) in an extended-release (ER) formulation. It is used to manage type 2 diabetes mellitus by improving insulin sensitivity and reducing glucose production in the liver.

Pioglitazone (15mg) improves insulin sensitivity, helping the body utilize glucose more effectively.
Metformin (500mg) decreases hepatic glucose production and increases peripheral glucose uptake.

Uses:

Management of type 2 diabetes mellitus
Helps control blood sugar levels in combination with diet and exercise
Suitable for patients not adequately controlled on monotherapy

How to Use:
Take the tablet as prescribed by your doctor, usually once daily with food to reduce gastrointestinal side effects. Swallow whole; do not crush, chew, or split the extended-release tablet.

Dosage:
Dosage is individualized based on blood sugar levels, treatment response, and other health conditions. Follow your doctor’s instructions strictly.

Precautions:

Inform your doctor if you have liver, kidney, or heart problems.
Use cautiously in patients with a history of heart failure or fluid retention.
Regular monitoring of blood sugar, liver function, and kidney function is recommended.
Avoid alcohol while on therapy.
Not suitable for type 1 diabetes or diabetic ketoacidosis.

Side Effects: